Ori­gi­nal-Re­se­arch: Ce­n­it AG (by GBC AG): BUY

Re­se­arch | 7 No­vem­ber 2025 10:00

Ori­gi­nal-Re­se­arch: Ce­n­it AG – from GBC AG

07.11.2025 / 10:00 CET/CEST
Dis­se­mi­na­ti­on of a Re­se­arch, trans­mit­ted by EQS News – a ser­vice of EQS Group.
The is­suer is so­le­ly re­spon­si­ble for the con­tent of this re­se­arch. The re­sult of this re­se­arch does not con­sti­tu­te in­vest­ment ad­vice or an in­vi­ta­ti­on to con­clude cer­tain stock ex­ch­an­ge tran­sac­tions.


Clas­si­fi­ca­ti­on of GBC AG to Ce­n­it AG

Com­pa­ny Name: Ce­n­it AG
ISIN: DE0005407100
Re­ason for the re­se­arch: Re­se­arch Com­ment
Re­com­men­da­ti­on: BUY
Tar­get pri­ce: EUR 16.00
Tar­get pri­ce on sight of: 31.12.2026
Last ra­ting ch­an­ge:
Ana­lyst: Cos­min Fil­ker, Mar­cel Gold­mann

Ana­ly­sis Prime weighs on re­ve­nue and ear­nings; fo­re­cast and pri­ce tar­get lo­we­red, BUY ra­ting con­firm­ed

Alt­hough CENIT AG achie­ved a slight in­crease in re­ve­nue of 1.8% to €154.20 mil­li­on af­ter nine months (pre­vious year: €151.43 mil­li­on), this growth was pri­ma­ri­ly at­tri­bu­ta­ble to the first-time in­clu­si­on of Ana­ly­sis Prime, which was ac­qui­red in July 2024. Ho­we­ver, this ef­fect is li­mi­t­ed to the first six months and, ac­cor­ding to our fin­dings, is li­kely to have amoun­ted to around €6 mil­li­on. Ad­jus­ted for this ef­fect, the com­pa­ny would have had to ac­cept a de­cli­ne in re­ve­nue of around 2% in the first nine months of 2025. This de­ve­lo­p­ment is in line with the ge­ne­ral­ly dif­fi­cult mar­ket si­tua­ti­on, which is af­fec­ting the au­to­mo­ti­ve in­dus­try in par­ti­cu­lar as CENIT AG’s most im­portant cus­to­mer sec­tor.

The dif­fi­cult mar­ket en­vi­ron­ment is par­ti­cu­lar­ly evi­dent in the fi­gu­res bro­ken down by sa­les groups. Sa­les of third-par­ty soft­ware (Das­sault, SAP, IBM) de­cli­ned to €74.34 mil­li­on (pre­vious year: €75.70 mil­li­on). Ho­we­ver, this was off­set by in­creased sa­les of high-mar­gin pro­prie­ta­ry soft­ware amoun­ting to €14.15 mil­li­on (pre­vious year: €13.63 mil­li­on). As ex­pec­ted, re­cur­ring re­ve­nues are be­co­ming in­cre­asing­ly im­portant. They now ac­count for 80.3% (pre­vious year: 76.4%) of re­ve­nues from CENIT soft­ware. Fi­nal­ly, con­sul­ting re­ve­nues show­ed the most vi­si­ble jump to €65.49 mil­li­on (pre­vious year: €61.98 mil­li­on). This is pri­ma­ri­ly due to the in­or­ga­nic ef­fect of the ac­qui­si­ti­on of Ana­ly­sis Prime in 2024.

De­spi­te the in­crease in sa­les, EBIT was si­gni­fi­cant­ly be­low the pre­vious ye­ar’s fi­gu­re of €3.97 mil­li­on at €-1.50 mil­li­on. This is pri­ma­ri­ly due to spe­cial ex­pen­ses for the im­ple­men­ta­ti­on of the ‘Pro­ject Per­for­mance’ res­truc­tu­ring pro­gram­me, which re­sul­ted in a re­duc­tion of just over 50 em­ployees. The pro­gram­me, which is now lar­ge­ly com­ple­te, led to a re­duc­tion in the work­force to 914 (31 De­cem­ber 2024: 984), while at the same time in­cur­ring spe­cial ex­pen­ses of €4.0 mil­li­on. The first po­si­ti­ve ef­fects were al­re­a­dy vi­si­ble in the third quar­ter, in which a si­gni­fi­cant re­duc­tion in per­son­nel ex­pen­ses was achie­ved com­pared to the first two quar­ters, lea­ding to a no­ti­ceable im­pro­ve­ment in EBIT to €2.18 mil­li­on (Q1 25: €-5.44 mil­li­on; Q2 25: €1.75 mil­li­on). An­o­ther fac­tor weig­hing on ear­nings was the ne­ga­ti­ve EBIT con­tri­bu­ti­on from Ana­ly­sis Prime, which to­tal­led €-2.6 mil­li­on in the first nine months of 2025.

CENIT AG is im­ple­men­ting a li­qui­di­ty-pre­ser­ving stra­tegy in the cur­rent 2025 fi­nan­cial year. Ac­cor­din­gly, no ac­qui­si­ti­ons are plan­ned for 2025. Tog­e­ther with the high ope­ra­ting cash flow of €12.59 mil­li­on (pre­vious year: €9.91 mil­li­on), cash and cash equi­va­lents im­pro­ved to €20.42 mil­li­on (31 De­cem­ber 2024: €16.46 mil­li­on). At the same time, bank lia­bi­li­ties were re­du­ced to €37.23 mil­li­on (31 De­cem­ber 2024: €49.03 mil­li­on), which led to a vi­si­ble im­pro­ve­ment in the ba­lan­ce sheet ra­ti­os.

For CENIT ma­nage­ment, the gui­dance ad­jus­ted in the 2025 half-year re­port re­mains va­lid even af­ter nine months. Re­ve­nue of at least €205 mil­li­on and EBIT of at least €-1.5 mil­li­on are still ex­pec­ted. In view of the fi­gu­res achie­ved in the first nine months, this fo­re­cast now ap­pears de­fen­si­ve. This is par­ti­cu­lar­ly the case in light of the res­truc­tu­ring me­a­su­res that have now been fi­na­li­sed. This me­ans that no fur­ther ex­tra­or­di­na­ry ex­pen­ses will be in­cur­red in the fourth quar­ter of 2025, but that the po­si­ti­ve sa­vings ef­fects should have an even grea­ter im­pact. Alt­hough Ana­ly­sis Prime is li­kely to re­port a ne­ga­ti­ve re­sult in the fourth quar­ter as well, this should be off­set by the po­si­ti­ve ef­fects.

We as­su­me that the fourth quar­ter, which is ty­pi­cal­ly the stron­gest quar­ter of the year for CENIT AG in terms of re­ve­nue, will re­main be­low the pre­vious ye­ar’s fi­gu­re, but that re­ve­nue growth will be achie­ved com­pared to the third quar­ter. We are the­r­e­fo­re main­tai­ning our re­ve­nue esti­ma­tes of €208.95 mil­li­on un­ch­an­ged. Ho­we­ver, we are ad­jus­ting our ex­pec­ted EBIT, which we are rai­sing to €0.82 mil­li­on (pre­vious­ly: €-0.28 mil­li­on). We as­su­me that the EBIT mar­gin for the fourth quar­ter will re­main un­ch­an­ged com­pared to the third quar­ter.

We are kee­ping our esti­ma­tes for the co­ming fi­nan­cial ye­ars un­ch­an­ged. In ad­di­ti­on to ri­sing sa­les, CENIT AG should be­ne­fit from cost ef­fects. Fur­ther­mo­re, CEN­I­T’s ma­nage­ment also ex­pects Ana­ly­sis Prime to make a po­si­ti­ve con­tri­bu­ti­on to ear­nings from 2026 on­wards. The ad­jus­t­ment of the esti­ma­tes for the cur­rent fi­nan­cial year has only a mi­nor im­pact on the re­sult of the DCF va­lua­ti­on mo­del, which is why we are main­tai­ning our pri­ce tar­get of €16.00 un­ch­an­ged. We con­ti­nue to as­sign a ‘BUY’ ra­ting.

You can down­load the re­se­arch here: 20251107_CENIT_Comment_engl

Cont­act for ques­ti­ons:
++++++++++++++++
Dis­clo­sure of po­ten­ti­al con­flicts of in­te­rest pur­su­ant to Sec­tion 85 WpHG and Art. 20 MAR The com­pa­ny ana­ly­sed abo­ve has the fol­lo­wing po­ten­ti­al con­flict of in­te­rest: (5a,6a,7,11); A ca­ta­lo­gue of po­ten­ti­al con­flicts of in­te­rest can be found at:

https://​www​.gbc​-ag​.de/​d​e​/​O​f​f​e​n​l​e​g​u​n​g​.​htm
+++++++++++++++
Date and time of com­ple­ti­on of the stu­dy: 06/11/25 (06:01 pm)
Date and time of the first dis­se­mi­na­ti­on of the stu­dy: 07/11/25 (10:00 pm)

Cont­act

Stu­dies

GBC AG
Hal­der­stra­ße 27
86150 Augs­burg

Te­le­fon: +49 821 241133–0
E‑mail: office(@)gbc-ag.de

Fol­low us!